Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BRIMONIDINE vs BROLUCIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BRIMONIDINE vs BROLUCIZUMAB: Safety Overview

Metric BRIMONIDINE BROLUCIZUMAB
Total FAERS Reports 11,830 682
Deaths Reported 59 41
Death Rate 0.5% 6.0%
Hospitalizations 367 105
Average Patient Age 62.4 yrs 69.5 yrs
% Female Patients 70.9% 57.1%
FDA Approval Date Apr 19, 2024 N/A
Manufacturer Somerset Therapeutics, LLC Novartis Pharmaceuticals Corporation
Route OPHTHALMIC INTRAVITREAL
Marketing Status Discontinued N/A